Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder

Psychiatric Genetics

Volumn 18, Issue 6, 2008, Pages 282-288

  Hossein Fatemi, S ^a,b   Reutiman, Teri J ^a   Folsom, Timothy D ^a   Lee, Susanne ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE   (United States)

Author keywords

Bipolar disorder; Cerebellum; Phosphodiesterase 4A; Schizophrenia; Western blotting

Indexed keywords

CYCLIC AMP; ISOENZYME; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV A5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; CEREBELLUM; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MULTIGENE FAMILY; PRIORITY JOURNAL; SCHIZOPHRENIA; TISSUE LEVEL;

ADULT; AGED; BIPOLAR DISORDER; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CEREBELLUM; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MIDDLE AGED;

EPICOCCUM;

EID: 57149142242     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283060fb8     Document Type: Article

References (41)

1. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, et al. (1996). Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci U S A 93:9985-9990.
2. Beauregard M, Leroux JM, Bergman S, Arzoumanian Y, Beaudoin G, Bourgouin P, et al. (1998). The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm. Neuroreport 9:3253-3258.
3. Beavo JA (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiolog Rev 75:725-748.
4. Beavo JA, Conti M, Heaslip RJ (1994). Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399-405.
5. Bender AT, Beavo JA (2006). Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520.
6. Berrettini W (2003). Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet 123:59-64.
7. Bolger GB (1994). Molecular biology of cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cell Signal 6:851-859.
8. Braun NN, Reutiman TJ, Lee S, Folsom TD, Fatemi SH (2007). Expression of phosphodiesterase 4 is altered in brain of subjects with autism. Neuroreport 18:1841-1844.
9. Cherry JA, Davis RL (1999). Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407:287-301.
10. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, et al. (2007). Behavioral phenotypes of disc 1 missense mutations in mice. Neuron 54:387-402.
11. Conti M, Swinnen JV, Tsikalas KE, Jin SL (1992). Structure and regulation of the rat high-affinity cyclic AMP phosphodiesterases. A family of closely related enzymes. Adv Second Messenger Phosphoprotein Res 25:87-99.
12. D'Sa C, Eisch AJ, Bolger GB, Duman RS (2005). Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci 22:1463-1475.
13. Dlaboga D, Hajjhussein H, O'Donnell JM (2006). Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram. Brain Res 1096:104-112.
14. Fatemi SH, King DP, Reutiman TJ, Folsom TD, Laurence JA, Lee S, et al. (2008). PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr Res 101:36-49.
15. Francis SH, Turko IV, Corbin JD (2001). Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 65: 1-52.
16. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, et al. (2006). Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15: 3024-3033.
17. Houslay MD (2001). PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Add Res Mol Biol 69:249-315.
18. Houslay MD, Adams DR (2003). PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370:1-18.
19. Houslay MD, Schafer P, Zhang KY (2005). Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10:1503-1519.
20. Iona S, Cuomo M, Bushnik T, Naro F, Sette C, Hess M, et al. (1998). Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Mol Pharmacol 53:23-32.
21. Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH (2004). Is the cerebellum relevant in the circuitry of neuropsychiatrie disorders? J Psychiatry Neurosci 30:178-186.
22. Krüger S, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS (2003). State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry 54: 1274-1283.
23. Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE, et al. (2007). Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet 144:129-158.
24. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P (2002). Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 159:1830-1840.
25. Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA (2002). Cerebellar blood volume in bipolar patients correlates with medication. Biol Psychiatry 51:370-376.
26. Loughney K, Ferguson K (1996). Identification and quantification of PDE isozymes and subtypes by molecular biological methods. In: Schudt C, Dent G, Rabe KF, editors. Phosphodiesterase inhibitors. San Diego: Academic Press, pp. 1-19.
27. Mennili FS, Faraci WS, Schmidt CJ (2006). Phosphodiesterases in the CNS. Natl Rev Drug Disc 5:660-670.
28. Miller JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, et al. (2005). DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310:1187-1191.
29. Miro X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, Mengod G (2002). Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43:1148-1157.
30. Murdoch H, Mackie S, Collins DM, Hill EV, Bolger GB, Klussmann E, et al. (2007). Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J Neurosci 27:9513-9524.
31. Nasrallah HA, Jacoby CG, McCalley-Whitters M (1981). Cerebellar atrophy in schizophrenia and mania, Lancet 1:1102.
32. Phillips ML, Drevets WC, Rauch SL, Lane R (2003). Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 54:515-528.
33. Picard H, Amado I, Mouchet-Mages S, Olie J-P, Krebs M-O (2008). The role of the cerebellum in schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences. Schizophr Bull 34:155-172.
34. Porteous DJ, Miller JK (2006). Disrupted in schizophrenia 1: building brains and memories. Trends Mol Med 12:255-261.
35. Qu M, Tang F, Yue W, Ruan Y, Lu T, Liu Z, et al. (2007). Positive association of the disrupted-in-schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 144:266-270.
36. Smith KA, Ploghaus A, Cowen PJ, McCleery JM, Goodwin GM, Smith S, et al. (2002). Cerebellar responses during anticipation of noxious stimuli in subjects recovered from depression. Functional magnetic resonance imaging study. Br J Psychiatry 181:411-415.
37. Takahashi M, Terwilliger R, Lane C, Mezes PS, Conti M, Duman RS (1999). Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci 19:610-618.
38. Torrey EF, Webster M, Knable M, Johnson N, Yolken RH (2000). The Stanley Foundation brain collection and neuropathology consortium. Schizophr Res 44:151-155.
39. Vazza G, Bertolin C, Scudellaro E, Vettori A, Boaretto F, Raminelli S, et al. (2007). Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol Psychiatry 12:87-93.
40. Ye Y, Conti M, Houslay MD, Farooqui SM, Chen M, O'Donnell JM (1997). Noradrenergic activity differentially regulates the expression of rolipramsensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain. J Neurochem 69:2397-2404.
41. Ye Y, Jackson K, O'Donnell JM (2000). Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain. J Neurochem 74:1257-1262.